Pricing Agreement
Exhibit 1.2
EXECUTION VERSION
Pricing Agreement
November 3, 2014
Barclays Capital Inc.
As representative of the several Underwriters
named in Schedule I (the “Representative”)
Ladies and Gentlemen:
Barclays PLC (the “Company”) proposes to issue US$2,000,000,000 aggregate principal amount of 2.75% Fixed Rate Senior Notes due 2019 (the “Notes”). Each of the Underwriters hereby undertakes to purchase at the subscription price set forth in Schedule II hereto, the amount of Notes set forth opposite the name of such Underwriter in Schedule I hereto, such payment to be made at the Time of Delivery set forth in Schedule II hereto. The obligations of the Underwriters hereunder are several but not joint.
Each of the provisions of the Underwriting Agreement—Standard Provisions, dated September 4, 2014 (the “Underwriting Agreement”), is incorporated herein by reference in its entirety, and shall be deemed to be a part of this Agreement to the same extent as if such provisions had been set forth in full herein; and each of the representations and warranties set forth therein shall be deemed to have been made at and as of the date of this Agreement, except that each representation and warranty with respect to the Prospectus in Section 2 of the Underwriting Agreement shall be deemed to be a representation and warranty as of the date of the Prospectus and also a representation and warranty as of the date of this Agreement in relation to the Prospectus as amended or supplemented relating to the Notes. Each reference to the Representatives herein and in the provisions of the Underwriting Agreement so incorporated by reference shall be deemed to refer to you. Unless otherwise defined herein, terms defined in the Underwriting Agreement are used herein as therein defined. The Representative designated to act on behalf of each of the Underwriters of Designated Securities pursuant to Section 14 of the Underwriting Agreement and the address referred to in such Section 14 is set forth in Schedule II hereto.
An amendment to the Registration Statement, or a supplement to the Prospectus, as the case may be, relating to the Designated Securities, in the form heretofore delivered to you, is now proposed to be filed with the Commission.
The Applicable Time for purposes of this Pricing Agreement is 3:50 PM New York time on November 3, 2014. Each “free writing prospectus” as defined in Rule 405 under the Securities Act for which each party hereto has received consent to use in accordance with Section 7 of the Underwriting Agreement is listed in Schedule III hereto and is attached as Exhibit A and Exhibit B hereto.
If the foregoing is in accordance with your understanding, please sign and return to us the counterpart hereof, and upon acceptance hereof by you, on behalf of each of the Underwriters, this letter and such acceptance hereof, including the provisions of the Underwriting Agreement incorporated herein by reference, shall constitute a binding agreement between each of the Underwriters on the one hand and the Company on the other.
| Very truly yours, |
| /s/ Xxx Xxxxx |
| Name: Xxx Xxxxx Title: Director, Capital Markets Execution |
| Accepted as of the date hereof at New York, New York On behalf of itself and each of the other Underwriters
BARCLAYS CAPITAL INC. |
| /s/ Xxxxx Xxxxx |
| Name: Xxxxx Xxxxx Title: Managing Director |
SCHEDULE I
| Underwriter |
Principal Amount of Notes | |||||||
| Barclays Capital Inc. |
US$ | 1,640,000,000 | ||||||
| Xxxxxxxx Xxxx Van, LLC |
US$ | 20,000,000 | ||||||
| BMO Capital Markets Corp. |
US$ | 20,000,000 | ||||||
| Capital One Securities, Inc. |
US$ | 20,000,000 | ||||||
| CIBC World Markets Corp. |
US$ | 20,000,000 | ||||||
| Xxxxxxxx Financial Group, Inc. |
US$ | 20,000,000 | ||||||
| Mizuho Securities USA Inc. |
US$ | 20,000,000 | ||||||
| Multi-Bank Securities, Inc. |
US$ | 20,000,000 | ||||||
| PNC Capital Markets LLC |
US$ | 20,000,000 | ||||||
| Santander Investment Securities Inc |
US$ | 20,000,000 | ||||||
| Scotia Capital (USA) Inc. |
US$ | 20,000,000 | ||||||
| SMBC Nikko Securities America, Inc. |
US$ | 20,000,000 | ||||||
| SunTrust Xxxxxxxx Xxxxxxxx, Inc. |
US$ | 20,000,000 | ||||||
| TD Securities (USA) LLC |
US$ | 20,000,000 | ||||||
| Telsey Advisory Group LLC |
US$ | 20,000,000 | ||||||
| The Korea Development Bank |
US$ | 20,000,000 | ||||||
| Xxxxxxxxx Capital Partners, LLC |
US$ | 20,000,000 | ||||||
| U.S. Bancorp Investments, Inc. |
US$ | 20,000,000 | ||||||
| Xxxxx Fargo Securities, LLC |
US$ | 20,000,000 | ||||||
|
|
|
|||||||
| Total |
US$ | 2,000,000,000 | ||||||
SCHEDULE II
Title of Designated Securities:
US$ 2,000,000,000 2.75% Fixed Rate Senior Notes due 2019
Price to Public:
99.648% of principal amount
Subscription Price by Underwriters:
99.323% of principal amount
Form of Designated Securities:
The Notes will be represented by one or more global notes registered in the name of Cede & Co., as nominee of The Depository Trust Company issued pursuant to the Senior Debt Securities Indenture expected to be entered into on November 10, 2014 between the Company and The Bank of New York Mellon acting through its London Branch, as trustee (the “Trustee”)
Securities Exchange, if any:
The New York Stock Exchange
Maturity Date:
The stated maturity of the principal of the Notes will be November 8, 2019.
Interest Rate:
Interest will accrue on the Notes from the date of their issuance. Interest will accrue on the Notes at a rate of 2.75% per year from and including the date of issuance.
Interest Payment Dates:
Interest will be payable semi-annually in arrear on May 8 and November 8 of each year, commencing on May 8, 2015 (short first interest period) and ending on the Maturity Date.
Record Dates:
The Business Day immediately preceding each Interest Payment Date (or, if the Notes are held in definitive form, the 15th Business Day preceding each Interest Payment Date).
Sinking Fund Provisions:
No sinking fund provisions.
Redemption Provisions for Notes:
The Notes are redeemable, at the option of the Company, in the event of various tax law changes that have specified consequences, as described further in, and subject to the conditions specified in, the prospectus supplement dated November 3, 2014 relating to the Notes.
Time of Delivery:
November 10, 2014 by 9:30 AM New York time.
Specified Funds for Payment of Subscription Price of Designated Securities:
By wire transfer to a bank account specified by the Company in same day funds.
Value Added Tax:
(a) If the Company is obliged to pay any sum to the Underwriters under this Agreement and any value added tax (“VAT”) is properly charged on such amount, the Company shall pay to the Underwriters an amount equal to such VAT on receipt of a valid VAT invoice;
(b) If the Company is obliged to pay a sum to the Underwriters under this Agreement for any fee, cost, charge or expense properly incurred under or in connection with this Agreement (the “Relevant Cost”) and no VAT is payable by the Company in respect of the Relevant Cost under paragraph (a) above, the Company shall pay to the Underwriters an amount which:
(i) if for VAT purposes the Relevant Cost is consideration for a supply of goods or services made to the Underwriters, is equal to any input VAT incurred by the Underwriters on that supply of goods and services, but only if and to the extent that the Underwriters are unable to recover such input VAT from HM Revenue & Customs (whether by repayment or credit) provided, however, that the Underwriters shall reimburse the Company for any amount paid by the Company in respect of irrecoverable input VAT pursuant to this paragraph (i) if and to the extent such input VAT is subsequently recovered from HM Revenue & Customs (whether by repayment or credit);
(ii) if for VAT purposes the Relevant Cost is a disbursement properly incurred by the Underwriters under or in connection with this Agreement as agent on behalf of the Company, is equal to any VAT paid on the Relevant Cost by the Underwriters provided, however, that the Underwriters shall use best endeavors to procure that the actual supplier of the goods or services which the Underwriters received as agent issues a valid VAT invoice to the Company.
Closing Location: Linklaters LLP, Xxx Xxxx Xxxxxx, Xxxxxx XX0X 0XX, Xxxxxx Xxxxxxx.
Name and address of Representative:
Designated Representative: Barclays Capital Inc.
Address for Notices:
Barclays Capital Inc.
000 Xxxxxxx Xxxxxx
Xxx Xxxx, XX 00000
Attn: Syndicate Registration
Selling Restrictions:
Each Underwriter of Designated Securities has represented, warranted and agreed that:
| a) | it has only communicated or caused to be communicated, and will only communicate or cause to be communicated, any invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Xxx 0000 (the “FSMA”)) received by it in connection with the issue or sale of any Designated Securities in circumstances in which Section 21(1) of the FSMA does not apply to the Company; and |
| b) | it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the Designated Securities in, from or otherwise involving the United Kingdom. |
With respect to sales of the Designated Securities in Canada, each Underwriter of Designated Securities represents to and agrees with the Company that, directly or indirectly, it shall sell the Designated Securities
only to purchasers purchasing as principal that are both “accredited investors” as defined in National Instrument 45-106 Prospectus and Registration Exemptions and “permitted clients” as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations.
Other Terms and Conditions:
As set forth in the prospectus supplement dated November 3, 2014 relating to the Notes, incorporating the Prospectus dated May 2, 2014 relating to the Notes.
SCHEDULE III
Issuer Free Writing Prospectus:
Final Term Sheet, dated November 3, 2014, attached hereto as Exhibit A.
Barclays PLC Fixed Income Investor Presentation: 2014 Interim Results, dated October 30, 2014, attached hereto as Exhibit B.
Exhibit A
Free Writing Prospectus
Filed Pursuant to Rule 433
Reg. Statement No. 333-195645
Pricing Term Sheet
| Issuer: | Barclays PLC | |
| Notes: | USD 2bn 2.75% Fixed Rate Senior Notes due 2019 | |
| Expected Issue Ratings1: | A3 (Xxxxx’x) / A- (S&P) / A (Fitch) | |
| Status: | Senior Debt / Unsecured | |
| Legal Format: | SEC registered | |
| Principal Amount: | USD 2,000,000,000 | |
| Trade Date: | November 3, 2014 | |
| Settlement Date: | November 10, 2014 (T+5) | |
| Maturity Date: | November 8, 2019 | |
| Coupon: | 2.75% | |
| Interest Payment Dates: | Semi-annually in arrear on May 8 and November 8 in each year, commencing on May 8, 2015 (short first interest period) and ending on the Maturity Date | |
| Coupon Calculation: | 30/360, following, unadjusted | |
| Business Days: | New York, London | |
| U.K. Bail-in Power Acknowedgement: | Yes. See section entitled “Description of Senior Notes—Agreement with Respect to the Exercise of U.K. Bail-in Power” in the Preliminary Prospectus Supplement dated November 3, 2014 (the “Preliminary Prospectus Supplement”). | |
| Tax Redemption | If there is a Tax Event (as defined in the Preliminary Prospectus Supplement), the Issuer may, at its option, at any time, redeem the notes, in whole but not in part, at a redemption price equal to 100% of their principal amount, together with any accrued but unpaid interest to (but excluding) the date fixed for redemption, as further described and subject to the conditions specified in the Preliminary Prospectus Supplement. | |
| Benchmark Treasury: | T 1 1⁄2 10/31/19 | |
| Spread to Benchmark: | 120 bps | |
| Reoffer Yield: | 2.826% | |
| Issue Price: | 99.648% | |
| Underwriting Discount: | 0.325% | |
| Net Proceeds: | USD 1,986,460,000 | |
| Sole Bookrunner: | Barclays Capital Inc. | |
| 1 | Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. |
| Co-managers: | Xxxxxxxx Xxxx Van, LLC; BMO Capital Markets Corp.; Capital One Securities, Inc.; CIBC World Markets Corp.; Xxxxxxxx Financial Group, Inc.; Mizuho Securities USA Inc.; Multi-Bank Securities, Inc.; PNC Capital Markets LLC; Santander Investment Securities Inc; Scotia Capital (USA) Inc.; SMBC Nikko Securities America, Inc.; SunTrust Xxxxxxxx Xxxxxxxx, Inc.; TD Securities (USA) LLC; Telsey Advisory Group LLC; The Korea Development Bank; Xxxxxxxxx Capital Partners, LLC; U.S. Bancorp Investments, Inc.; Xxxxx Fargo Securities, LLC. | |
| Risk Factors: | An investment in the notes involves risks. See “Risk Factors” section beginning on page S-11 of the Preliminary Prospectus Supplement. | |
| Denominations: | USD 200,000 and integral multiples of USD 1,000 in excess thereof | |
| ISIN/CUSIP: | XX00000XXX00 / 00000XXX0 | |
| Xxxxxxxxxx: | DTC; Book-entry; Transferable | |
| Documentation: | To be documented under the Issuer’s shelf registration statement on Form F-3 (No. 333-195645) and to be issued pursuant to the Senior Debt Indenture expected to be entered into on November 10, 2014 between the Issuer and The Bank of New York Mellon acting through its London Branch, as trustee (the “Trustee”) | |
| Listing: | We will apply to list the notes on the New York Stock Exchange | |
| Governing Law: | New York law | |
| Definitions: | Unless otherwise defined herein, all capitalized terms have the meaning set forth in the Preliminary Prospectus Supplement | |
The issuer has filed a registration statement (including a prospectus dated May 2, 2014 (the “Prospectus”) and the Preliminary Prospectus Supplement) with the U.S. Securities and Exchange Commission (“SEC”) for this offering. Before you invest, you should read the Prospectus and the Preliminary Prospectus Supplement for this offering in that registration statement, and other documents the Issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by searching the SEC online database (XXXXX®) at xxx.xxx.xxx. Alternatively, you may obtain a copy of the Prospectus and the Preliminary Prospectus Supplement from Barclays Capital Inc. by calling 0-000-000-0000.
Exhibit B
Free Writing Prospectus
Filed Pursuant to Rule 433
Reg. Statement No. 333-195645
|
|
Free Writing Prospectus
Filed Pursuant to Rule 433
Reg. Statement No. 333-195645
Fixed Income Investor Presentation
Q3 2014 Interim Management Statement
30 October 2014
|
|
PERFORMANCE OVERVIEW
Performance Overview
2 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
PERFORMANCE OVERVIEW
Summary Group financials: Good Core results and Non-Core progress
Nine months ended – September (£m)
Income
Impairment
Total operating expenses
– Litigation and conduct
– Costs to achieve Transform (CTA)
Adjusted profit before tax
Tax
NCI and other equity interests
Adjusted attributable profit
– Own credit
– Provisions for PPI and IRHP redress
– Gain on US Xxxxxx acquisition assets
– Provision for ongoing investigations
Adjustments into Foreign Exchange
– Loss on announced sale of the
Spanish business
Statutory profit before tax
Statutory attributable profit
Return on average equity1
2013 2014
21,257 19,710
(2,353)(1,595)
(14,144)(13,186)
(164)(309)
(741)(826)
4,717 4,939
(1,505)(1,630)
(629)(721)
2,583 2,588
(125) 96
(2,000)(910)
259 461
–(500)
–(364)
2,851 3,722
1,182 1,505
6.6% 6.3%
Financial performance
Adjusted profit increased by 5% to £4.9bn as improvements in PCB and Barclaycard were partly offset by reduced income in the Investment Bank and currency movements in Africa Banking
Adjusted income decreased 7% while impairment reduced by 32% due to continued strong credit risk management, resulting in a 4% decrease in net operating income to £18.1bn
Steady progress on operating expenses with total Group cost base falling by 7% to £13.2bn
Group headcount reduction of c.8,000 (gross) since December 2013
Adjusted attributable profit was £2.6bn, resulting in EPS of 16.1p
Group XxX fell to 6.3%, including costs to achieve Transform, while Core XxX was 10.5%
Barclays Non-Core loss before tax reduced by 33% to £648m, and XxX drag fell to 4.2%
Statutory profit before tax was £3.7bn, up 31%
Q3 2014 adjusting items include additional PPI provision of £170m and IRHP provision release of £160m
1 Based on adjusted attributable profit, also taking into account tax credit on AT1 coupons |
3 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
PERFORMANCE OVERVIEW
Strengthening key financial metrics
(£bn)
Total assets
Balance
BCBS leverage exposure1
Sheet
BCBS leverage ratio1
Fully loaded CET1 ratio2
CRD IV Fully loaded CET1 capital
Capital Fully loaded T1 capital
Risk weighted assets
Liquidity Coverage Ratio3
Liquidity
Net Stable Funding Ratio3
Loan to deposit ratio5
Funding
Wholesale funding6
Jun-14 Sep-14
1,315 1,366
1,353 1,324
3.4% 3.5%
9.9% 10.2%
40.8 42.0
45.4 46.6
411 413
107% 115%
98% –4
92% 90%
179 178
Highlights
Key balance sheet metrics continues to strengthen
Fully loaded capital metrics showed steady progress with fully loaded CRD IV CET ratio at 10.2% and BCBS leverage ratio at 3.5%
Liquidity pool increased to £146bn, comprising 85% cash and deposits with central banks and high quality government bonds
LCR was above 100% requirement with a surplus of £20bn
Funding profile remained conservative with Loan to Deposit Ratio of 90% in retail and corporate businesses
Wholesale funding outstanding was £178bn, of which £85bn matures in <1 year
| 1Estimates based on current understanding of the BCBS 270 standards and the requirements contained in the European Commission delegated act | 2 Based on our interpretation of the final CRD IV text and latest EBA technical standards | 3 Based on CRD IV rules, as implemented by the EBA | 4 Calculated biannually | 5 LDR calculated for PCB, Africa Banking, Barclaycard and Non-Core retail | 6 Excludes repurchase agreements
4 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
PERFORMANCE
OVERVIEW
Core business performing well
Nine months ended – September (£m)
Income
Impairment
Total operating expenses
– Litigation and conduct
– Costs to achieve Transform (CTA)
Adjusted profit before tax
Tax
NCI and other equity interests
Adjusted attributable profit
Adjusted financial performance measures
Average allocated equity1
Return on average tangible equity
Return on average equity
Cost : income ratio
Basic EPS contribution
CRD IV RWAs
BCBS leverage exposure2
2013 2014
19,414 18,682
(1,629) (1,429)
(12,174) (11,719)
(104) (194)
(306) (655)
5,682 5,587
(1,666) (1,774)
(537) (587)
3,479 3,226
£35bn £41bn
16.9% 12.8%
13.3% 10.5%
63% 63%
25.6p 20.0p
Jun-14 Sep-14
£324bn £332bn
c.£970bn £1,007bn
Financial performance
Good overall performance with PBT broadly in line at £5.6bn:
- PCB and Barclaycard profits up 18% and 21% respectively; and
- Africa Banking profits up 11% on a constant currency basis; which helped offset
- Investment Bank profits down 38%
Income fell 4% to £18.7bn, reflecting lower Investment Bank income and a weaker Rand which reduced Africa Banking income
Net Interest Income (NII) for PCB, Barclaycard and Africa Banking increased 3.7% to £8.5bn reflecting growth in lending and margin
Continued strong credit quality led to a 12% improvement in impairment
Cost discipline continued with operating expenses down 4% to £11.7bn with positive jaws across all businesses excluding CTA
Core attributable profit was £3.2bn with Core EPS of 20p
Core XxX was 10.5% (12% excluding CTA) on average allocated equity of £41bn
1 Average allocated equity for preceding nine months | 2 Estimates based on current understanding of the BCBS 270 standards and the requirements contained in the European Commission delegated act |
5 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
PERFORMANCE
OVERVIEW
Barclays Non-Core: Continued shrinkage and capital return
Nine months ended – September (£m) 2013 2014
Income 1,843 1,028
Impairment(724)(166)
Total operating expenses(1,970)(1,467)
– Costs to achieve Transform (CTA)(435)(171)
Loss before tax(965)(648)
Tax 161 144
NCI and other equity interests(92)(134)
Attributable profit / (loss)(896)(638)
Financial performance measures
Average allocated equity1 £17bn £14bn
Return on average tangible equity drag(9.2%)(5.4%)
Return on average equity drag(6.7%)(4.2%)
Basic EPS contribution(6.6p)(3.9p)
Jun-14 Sep-14
CRD IV RWAs £87bn £81bn
BCBS leverage exposure2 c.£385bn £317bn
Highlights
Loss before tax reduced by 33% to £648m as improvements in impairments and costs were partially offset by significant declines in income due to sales and paydowns of securities and loans and reduced investment banking activity
2013 CTA spend reflects restructuring in Europe, with the subsequent savings flowing through 2014 operating expenses
The income and costs relating to Spain will exit on completion, with a c.£250m reduction in annualised income, offset by c.£240m saving in gross costs
Average allocated equity reduced by £3.6bn to £13.8bn
Reduced loss and lower allocated equity reduced drag on Group XxX to 4.2%, well within the 6% to 3% drag guidance
1 Average allocated equity for preceding nine months | 2 Estimates based on current understanding of the BCBS 270 standards and the requirements contained in the European Commission delegated act |
6 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
CAPITAL &
LEVERAGE
Capital & Leverage
7 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
CAPITAL & LEVERAGE
Progressive strengthening of capital and leverage ratios
Fully loaded CRD IV CET1 ratio1
Spain 10.4%
c.20bps2
>11%
10.5%
9.9% 10.2%
9.1%
Dec-13 Jun-14 Sep-14 2015 2016
Milestone Target
Estimated BCBS leverage ratio3
>4%
3.4% 3.5% 3.5%
3.0%
Dec-13 Jun-14 Sep-14 2015 2016
Milestone Target
Highlights
Continue to show good progress on our CRD IV CET1 ratio and estimated BCBS leverage ratio towards 2016 targets
Fully loaded CRDIV CET1 capital strengthened in Q3 by £1.3bn to £42bn. Excluding the loss on the announced sale of the Spanish business, profits in the period generated £0.8bn of CET1 capital
RWAs remained broadly flat at £413bn
Fully loaded CRD IV CET1 ratio reached 10.2% at the end of September 2014, and would have been 10.4% with benefit of the Spain transaction2, representing good progress towards our 2016 target of >11%
The estimated Basel Committee on Banking Supervision (BCBS) 270 leverage exposure decreased to £1,324bn (June 2014: £1,353bn) primarily driven by a reduction in reverse repurchase agreements and derivative exposures
Leverage ratio increased to 3.5%
Confident that our planned trajectory of capital and leverage positions us well to meet future regulatory requirements
1 Based on our interpretation of the final CRD IV text and latest EBA technical standards. Following the full implementation of CRD IV reporting in 2014, the previously reported 31 December 2013 RWAs have been revised by £6.9bn to £442bn and fully loaded CET1 ratio revised by (0.2%) to 9.1% | 2 Estimate as announced on 1 September 2014, subject to valuation upon completion of the sale | 3 Estimates based on current understanding of the BCBS 270 standards and the requirements contained in the European Commission delegated act |
8 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
RWAs: Well managed to support business growth and returns
RWAs (£bn)
Highlights
411 2 4(7) 3 413
c.8 1 Spain
RWAs were up marginally on the quarter as reductions in Non-Core were offset by growth in Core businesses, and model and methodology driven movements
Underlying reductions in Non-Core mainly driven by derivative optimisation and legacy asset sell down, with further reductions of investment banking positions
Model changes mainly impacted Non-Core and the Core Investment Bank driven by a number of smaller model adjustments
Upon completion of the sale of the Spanish businesses, RWAs are expected to decrease by a further £8bn1
As Non-Core is run-down, and capital released is allocated to the Core Businesses, the mix of RWAs is expected to change
Jun-14 Model and Core Non-Core Other Sep-14
methodology business run-down 2
updates growth
1 Estimate as announced on 1 September 2014, subject to valuation upon completion of the sale | 2 Net of model and methodology driven movements |
9 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
CAPITAL &
LEVERAGE
Continued progress on the transition towards our ‘target’ end-state capital structure
Evolution of capital structure
16.4%
Total capital ratio
3.5%
(£14.5bn)
T2
1.8% (£7.4bn)
Legacy T1
CCCB/
1.1% (£4.3bn) XX0 Xxxxxxxx
buffers
10.0%1
(£41.4bn)
CET1
?17% Total capital ratio
3.1%
T2 (incl. P2A)
Max 1.5%
Internal buffer
2.0%
G-SII
2.5% Capital Conservation buffer
2.0% AT1 (incl. P2A)
1.4% P2A
4.5% CET1
Barclays’ Q3 14 capital structure (PRA Transitional)
Barclays’ ‘target’ end-state capital structure
Fully loaded CRD IV capital position
Fully loaded CRD IV CET1 ratio at 10.2% on track to meet our target of > 11% in 2016. The ratio was well in excess of the 7% PRA regulatory target2
Robust buffers to contingent capital triggers3
AT1 contingent capital: 320bps or £13.1bn
T2 contingent capital: 510bps or £21.1bn4
As we build CET1 capital over the transitional period, we expect reaching a range of 11.5-12% in end-state5
Continued transition towards our end-state capital through issuance of most of our CRD IV and PRA compliant capital and term senior unsecured debt out of Barclays PLC
Fully loaded total capital ratio increased to 15.4% (30 June 2014: 15.0%) and transitional total capital ratio increased to 16.4% (30 June 2014: 16.0%)
Further clarity required on Total Loss Absorbing Capacity (TLAC) quantum and composition. In the interim, we continue to build towards our target end-state capital structure which assumes at least 17% of total capital; final requirements subject to PRA discretion
Pillar 2A guidance
As per PS7/136, PRA expects UK banks to meet Pillar 2A by 1 January 2015. Barclays Pillar 2A requirement for 2014 is 2.5%7
- CET1 of 1.4% (assuming 56%)
- AT1 of 0.5% (assuming 19%)
- T2 of 0.6% (assuming 25%)
Individual capital guidance determining Pillar 2A will be set and communicated at least annually, and will vary accordingly
1 Difference to fully loaded ratio of 10.2% arises from a regulatory adjustment relating to unrealised gains | 2 Being the higher of 7% PRA expectation and CRD IV capital requirements | 3 CRD IV rules on mandatory distribution restrictions apply from 1 January 2016 onwards based on transitional CET1 requirements | 4 Based on the CRD IV CET1 transitional (FSA October 2012 statement) the ratio was 12.1% as at 30 September 2014 | 5 Pillar 2A requirements for 2014 held constant out to end-state for illustrative purposes. The PRA buffer is assumed to be below the CBR of 4.5% in end-state albeit this might not be the case. CCCB, other systemic and sectoral buffer assumed to be zero | 6 The PRA intends to consult on its Pillar 2 proposal during 2014. The EBA is also developing guidelines on Pillar 2 capital which are likely to affect how the PRA approaches Pillar 2 | 7 Point in time assessment made at least annually, by the PRA, to reflect idiosyncratic risks not fully covered under Pillar 1. The PRA has stated (in CP5/13) that capital that firms use to meet their minimum requirements (Pillar 1 and Pillar 2A) cannot be counted towards meeting buffers |
10 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
CAPITAL &
LEVERAGE
Progressive implementation of CET1 requirements
Regulatory targets, excluding internal buffer
CRD IV minimum CET1 requirement
Pillar 2A met with CET1 capital (varies annually)
Fully loaded combined buffer requirement, excluding CCCB
PRA regulatory minimum1
Barclays fully loaded CRD IV CET1 ratio progression
Estimated Mgmt.
10.5% 11.5-12% buffer
10.2% <1.5%
as at 30-Sep-2014
7% 7% 4.5%
1.4% 1.4%2
4% 4.5% 4.5%
2014 2015 2019
Key assumptions in this illustration
CET1 minimum requirements per PRA implementation of Capital Requirements Regulation (CRR)
Pillar 2A met with CET1 capital for 2014 is 1.4% of RWAs; subject to at least annual review2, we hold it constant in 2019 for illustration purposes
Combined buffer requirement (and associated rules for mandatory distribution restrictions), consisting of 2.5% capital conservation buffer and 2% G-SII buffer, transitions in from 1 January 2016 at 25% per annum
In 2019, we have assumed that the PRA buffer will be less than 4.5% combined buffer requirement; however, this may not be the case
Countercyclical (CCCB), other systemic and sectoral buffers are currently assumed to be zero3
Internal management buffer, currently 1.5%, will be recalibrated over time and may be less than 1.5% by 2019
Note: during 2014, the PRA will refresh its “PRA buffer” following its stress testing exercise. In 2015, the combined CRD IV minimum requirements, Pillar 2A and PRA buffer may be greater than 7.0%
1 Being the higher of 7% PRA expectation and CRD IV capital requirements | 2 Held constant for illustration | 3 These buffers could be applied at the Group level, or at a legal entity, sub-consolidated or portfolio level |
11 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
CAPITAL &
LEVERAGE
We intend to manage our CET1 capital ratio to mitigate against the risk of mandatory distribution restrictions
CET1 requirements1 (as at 1 January except Q3 14)
Minimum CET1 ratio
Pillar 2A
Capital conservation buffer (CET1)
G-SII buffer (CET1)
Trajectory of fully loaded CET1 ratio, assuming >11% target is met after which we build towards 11.5-12% in end state3
Distributions subject to MDA restrictions
Sliding scale of restrictions
11.5-12%
12% >11.0%
10.5%
10.2% 10.4%
10% 9.3% 2.0%
8.2% 1.5%
8% 7% 1.0%
0.5% 1.3% 1.9% 2.5%
6% 0.6%
1.4% 1.4% 1.4% 1.4% 1.4% 1.4%
4%
2% 4.0% 4.5% 4.5% 4.5% 4.5% 4.5%
0%
Q3 14 2015 2016 2017 2018 2019
Estimated buffers1 (fully loaded CET1 ratio vs. AT1 7% trigger and vs. MDA restrictions)
To AT1 7% trigger c.£13bn c.£14bn > £ 16bn c.£ 17bn c.£18bn c.£18-20bn
To MDA restriction n/a n/a > £ 16bn c.£ 12bn c.£9bn c.£4-6bn
Mandatory restrictions to discretionary distributions2 will apply to all European banks, under CRD IV, from 1 January 2016 (Art. 162.2 of CRD)
As outlined in Art. 141 of CRD, mandatory distribution restrictions apply if an institution fails to meet the combined buffer requirement (CBR)3 at which point a Maximum Distributable Amount (MDA) is calculated on a reducing scale
CBR is phased in from 2016. In end state, we intend to hold an internal management buffer of up to 150bps above CBR providing prudent headroom to the MDA restriction point
Until 1 January 2017, the assumed effective floor for mandatory restrictions on interest payment will be the AT1 7% fully loaded CET1 trigger, stepping up to 10.4% by 2019 when the CRD IV transitional rules are fully phased in
Barclays expects to have full discretion in the allocation of permitted distributions within the MDA
1 This analysis is presented for illustrative purposes only and is not a forecast of Barclays’ results of operations or capital position or otherwise. The analysis is based on certain assumptions (including meeting the >11% CET1 ratio target in 2016, straight line progression towards 11.5-12% in end-state, and that the P2A requirement for 2014 is constant out to 2019 which may not be the case as the requirement is subject to at least annual review) which cannot be assured and are subject to change | 2 Dividends on ordinary shares, interest payments in respect of AT1 securities and variable compensation | 3 As per Art. 128(6) of CRD: total CET1 capital required to meet the requirement for the capital conservation buffer, as well as an institution specific countercyclical buffer (CCCB), G-SII buffer, O-SII buffer and systemic risk buffer as applicable. For Barclays this is currently the 2.5% Capital Conservation Buffer and 2% G-SII buffer while the CCCB and other systemic risk and sectoral buffers are assumed to be zero |
12 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
CAPITAL &
LEVERAGE
Steady progression on leverage ratio
BCBS leverage exposure1 (£bn)
L&A and other assets2
SFTs
BCBS leverage ratio1
Derivatives
Undrawn commitments
3.4% 3.5%
1,353 1,324
105 110
228 192
288 279
732 743
H1 14 Q3 14
Highlights
Estimated BCBS leverage ratio improved further as a result of regulatory capital accretion and additional deleveraging
Continue to make good progress on deleveraging, reducing expected BCBS leverage exposure by £29bn, including:
IFRS reverse repurchase agreements decreased £14bn to £158bn and Securities Financing Transactions (SFT) adjustments reduced £22bn to £34bn due to lower match book trading and optmisations
IFRS derivatives increased £50bn to £383bn, which was broadly offset by a £47bn increase in allowable netting to £345bn. Eligible cash collateral netting increased £11bn to £42bn, driven by business activity and optimisations
1 Estimates based on current understanding of the BCBS 270 standards and the requirements contained in the European Commission delegated act | 2 Loans and advances and other assets net of regulatory deductions and other adjustments |
13 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
LIQUIDITY &
FUNDING
Liquidity & Funding
14 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
LIQUIDITY &
FUNDING
Balance sheet is conservatively funded
Balance sheet structure—£1.3tn (excl. BAGL), 30 Sep 14 (£bn)
Derivatives, 378
Reverse repo, 158
Trading portfolio assets, 56
Other matched assets1, 89
Customer loans & advances, 330
Liquidity pool, 146
Other assets3, 154
Total Assets
Derivatives, 378
Matched
funding
£680bn
Repo, 160
Trading portfolio liabilities, 54
Other matched liabilities1, 89
99%
Group
Customer deposits, 341
LDR2
<1 year wholesale funds, 85
>1 year wholesale funds, 93
Other liabilities4, 49
Equity, 61
Total Liabilities and Equity
Highlights
Derivative assets and liabilities largely matched
Trading portfolio assets and reverse repurchase agreements are largely funded in wholesale markets by repurchase agreements and trading portfolio liabilities
Customer loans and advances largely funded by customer deposits
LDR for PCB, Barclaycard and Africa Banking broadly unchanged at 90%5
Decreasing reliance on wholesale funding (£178bn as at 30 September 2014, down £62bn since 31 December 2012)
Liquidity pool predominantly funded through wholesale markets, and well in excess of short-term funding requirements
1 Matched cash collateral and settlement balances | 2 The Group Loan to Deposit Ratio (LDR) includes BAGL, cash collateral and settlement balances | 3 Including L&A to banks, financial assets at fair value, AFS securities (excluding liquidity pool), unencumbered trading portfolio assets, and excess derivative assets | 4 Including excess cash collateral and settlement balances | 5 Also includes the Non-core (retail) deposits |
15 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
LIQUIDITY &
FUNDING
Maintaining a robust liquidity position, with pool well in excess of internal and external minimum requirements
High quality liquidity pool (£bn)
Cash & Deposits at Central Banks Government Bonds
Other Available Liquidity
150 146
127
19 22
46 22
74
62
85
43 50
2012 2013 Sep-14
Estimated CRD IV/Basel 3 liquidity ratios1
Metric Jun-14 Sep-14 Expected 100% requirement date
LCR2 107% 115% 1 January 2018
NSFR3 98% – 1 January 2018
Surplus to 30-day Barclays-specific LRA4
2013 Jun-14
LRA 104% 107%
Buffer £5bn £9bn
Key messages
Further strengthened liquidity position with the Group liquidity pool up by £12bn to £146bn, building a larger surplus to the internal Liquidity Risk Appetite
Quality of the pool remains high despite on-going optimisation of its composition:
85% held in cash, deposits with central banks and high quality government bonds
Over 86% of government bonds are securities issued by UK, US, Japanese, French, German, Danish, Swiss and Dutch sovereigns
Even though not a regulatory requirement, our liquidity pool exceeds wholesale debt maturing in less than a year
Additional significant sources of contingent funding in the form of high quality assets pre-positioned with central banks globally
Continued strengthening of estimated CRD IV/Basel 3 liquidity ratios1:
Estimated LCR in excess of 100% expectation in January 2018 based on both the CRD IV rules as implemented by the EBA and the Basel Standards
Rules on the NSFR are still evolving and subject to consultation. Expect to be in excess of 100% well ahead of the 2018 implementation timeline even if rules were to be implemented in current form
1 Includes a number of assumptions which are subject to change prior to the implementation of the CRD IV liquidity requirements | 2 LCR estimated based on CRD IV rules as implemented by the EBA | 3 Disclosed on a semi-annual basis. Estimated based on our interpretation of the Basel Consultation Paper published in January 2014, including the requirement for 50% required stable funding against short-term reverse repos from non-banks. Without this interpretation of the requirement, which did not exist in the 0000 Xxxxx publication, the NSFR as at 30 June 2014 would have been 113%. Further changes to the rules are expected prior to the Basel Committee’s finalisation of the rules and implementation by local regulators ahead of the target 2018 compliance date | 4 Disclosed on a semi-annual basis |
16 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
LIQUIDITY &
FUNDING
We maintain access to stable and diverse sources of funding, across customer deposits and wholesale debt
Significant increase in deposit funding (£bn)
101%
110% 99%
424 429 432 442 438
300 385
2012 2013 Sep-14
Deposits from customers
Group LDR L&A to customers
L&A to customers
Total funding (excluding BAGL)
Customer deposits Secured term funding Sub. debt
Short-term debt and other deposits Unsecured term funding
£540bn £522bn £509bn
16% 14% 13%
20% 14% 15%
7% 5%
4% 7% 4% 4%
53% 62% 63%
2012 2013 H1 2014
Key messages
Group Loan to Deposit Ratio (LDR) and the LDR for PCB, Barclaycard and Africa Banking broadly unchanged at 99% and 90% respectively1
Excess customer deposits in PCB, Barclaycard and Africa Banking are predominantly used to fund the liquidity buffer requirements for these businesses, making them broadly self funded
In line with the 2014 funding plan, the Group issued £4bn of term funding net of early redemptions during X0 0000, taking total net issuance in 2014 to £14bn (excluding FLS)
2014 Funding Plan
£4bn of term funding maturing in the remainder of 2014. A further £23bn matures in 2015
We intend to maintain access to diverse wholesale funding, through different products, currencies, maturities and channels
We will continue to look for issuance opportunities across public and private unsecured, and secured transactions, and subordinated debt, although will still be materially below overall maturities for the year
Secured debt issuance from established platforms expected to continue supporting unsecured issuances, contributing to the stability and diversity of our funding base
1 LDR for PCB, Barclaycard and Africa Banking also includes the Non-Core (retail) deposits |
17 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
LIQUIDITY &
FUNDING
Continue to access diverse wholesale funding sources across multiple products, currencies and maturities
Wholesale funding by product (as at 30 June 2014)
7% 13%
10%
15%
14%
3%
12%
27%
Deposits from banks
CDs and CPs
ABCPs
Public benchmark MTNs
Privately placed MTNs
Covered bonds / ABS
Subordinated liabilities 1
Other 2
By remaining maturity1: WAM net of liquidity pool >80 months
12%
24%
14%
6%
18%
11%
10% 5%
£1 month
>1 mth but <3 mths
>3 mths but <6 mths
>6 mths but <9 mths
>9 mths but <12 mths
> 1 year but <2 years
> 2 year but <5 years
> 5 years
By currency1 USD EUR GBP Others
As at 30 June 2014 35% 36% 18% 11%
As at 31 December 2013 35% 36% 19% 10%
Key Messages
Overall stock of wholesale funding continues to fall as we de-lever the balance sheet, with total wholesale funding (excluding repurchase agreements) of £178bn as at 30 September 2014, a reduction of £62bn since 2012 (31 December 2013: £186bn)
£85bn matures in less than one year, while £21bn matures within one month (31 December 2013: £82bn and £20bn respectively)
£4bn of term funding (net of early redemptions) issued in Q3 2014, taking total net issuance to £14bn in 2014. Q3 2014 activity includes:
c.£1.6bn across senior unsecured and a Tier 2 deal issued by Barclays PLC
£1.5bn of Covered bonds, as well as c.£1.2bn US and UK credit card backed securities, issued by Barclays Bank PLC
We have £4bn of term funding maturing in the remainder of this year. We expect to look for issuance opportunities across unsecured, secured and capital and still be materially below overall maturities for the year of £23bn
1 Given different accounting treatments, AT1 capital is not included in outstanding subordinated liabilities, while T2 contingent capital notes are included | 2 Primarily comprised of fair valued deposits (£4bn) and secured financing of physical gold (£5bn) |
18 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
ASSET QUALITY
Asset quality
19 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
ASSET QUALITY
Continued strong asset quality
Impairment charge (£m)
1,629
1,429
Q3 YTD 13 Q3 YTD 14
Impairment allowance (£m)
4,569 4,466
31-Dec-13 30-Sep-14
90-day delinquency trends
UK mortgages
0.7%
South Africa mortgages 0.2%
Q1 13 Q2 13 Q3 13 Q4 13 Q1 14 Q2 14 Q3 14
Impairment continued to benefit from strong asset quality with Core impairment falling 12% to £1.4bn, with an impairment release in the Investment Bank and lower charges across all other businesses year-on-year
PCB benefitted from the improving economic environment in the UK
Africa Banking saw improvements in the South African mortgage portfolio
Impairment allowances have fallen by 2% reflecting lower balances in the wholesale portfolios in part due to releases and recoveries in the period
The CRL coverage ratio has remained broadly unchanged reflecting stable credit metrics
UK mortgage delinquency rates remained broadly stable, reflecting high quality mortgage books
South African mortgage delinquency reflected continuing improvement in the Home Loans portfolio, as action taken in prior years benefitted the quality of the overall portfolio
20 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
ASSET QUALITY
Group impairment improved 32%, with positive trends across businesses
Retail loan loss rate (bps)1
H1 14 Q3 14
311 301
162 139
85 82 80 78
54 52
19 19
Personal & Corporate Banking
Africa Banking Barclaycard Core Non-Core Group
Wholesale loan loss rate (bps)1
H1 14 Q3 14 44
38 36
24 27
19
14 13
9 11
(4) (2)
Investment Bank Personal Corporate Banking
& Africa Banking Core Non-Core Group
Highlights
Declining Loan Loss Rate (LLR) trend across the Group reflecting Barclays’ well-managed and conservative risk profile
The Group annualised LLR of 43bps remains significantly below the longer term average of 90bps
Group impairment charges improved 32% year-on-year to £1.6bn (30 September 2013: £2.4bn), principally reflecting lower charges in Personal & Corporate Banking, Africa Banking and Non-Core
Group LLRs declining in both retail and wholesale in line with improving macro economic conditions
LLR = Annualised impairment charge Gross loans and advances
1 Annualised |
21 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
ASSET QUALITY
Reduced exposure to Eurozone periphery1
Exposures by geography (£bn)
Spain Italy Portugal Ireland
59.0
4.9 52.8
7.9 6.7 47.1
6.3 4.6
5.4
22.7
20.6 19.8
23.5 19.2 17.3
2012 2013 H1 2014
Exposures by asset class (£bn)
Sovereign Financial institutions Corporate
Residential mortgages Other retail lending
59.0
6.2 52.8
5.8 47.2
5.0
32.5
31.3 29.3
9.2 6.9
5.7 6.2
5.4 6.5 2.2 4.4 2.2
2012 2013 H1 2014
Key Messages
Active management of exposure to Eurozone periphery countries
Exposure to Spain, Italy, Portugal and Ireland reduced further, down 11% to £47.1bn in H1 2014 as financial institution exposures decreased to £4.4bn and residential mortgage exposure decreased to £29.3bn
Barclays repaid €3bn of funding raised through the ECB’s three year LTRO during 2013, leaving €5bn outstanding as at
30 June 2014 (31 December 2012: €8bn)
Local net funding mismatches remained stable
- Spain: €2.4bn funding surplus
- Portugal: €2.6bn funding gap
- Italy: €10.8bn funding gap2
Completion of the disposal of the Spanish businesses expected around year end
We continue to explore options to exit our other European retail and corporate exposures or materially reduce the capital they consume
1 As at H1 2014 | 2 Redenomination risk significantly lower in Italy where we also have collateral available to support additional secured funding should the risk increase
22 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
ASSET QUALITY
Barclays Non-Core: Progress on RWAs and leverage reductions
RWA reduction (£bn)
Businesses Securities and loans
Derivatives Operational risk and DTA
110
9
87
33 81 80
10
9 c.7 Spain
1
29
27
50
44 c.7
c.385
73
28 26 317 c.300
43
180
24 20 19
Dec-13 Jun-14 Sep-14 2014 2016 Jun-14 Sep-14 2014 2016
Target Target Target Target
Highlights
RWA reductions since the year end have concentrated in securities and loans sales and paydowns
RWAs reduced by £6bn in Q3 2014 mainly driven by derivative optimisation and legacy asset sell down, with further reductions of investment banking positions
On completion of the sale of the Spanish business, a further reduction of c.£7bn RWAs in Non-Core will be recognised
Leverage exposure also reduced, with the BCBS measure down to £317bn, driven principally by lower SFTs and derivative exposures
BCBS leverage exposure and targets2 (£bn)
1 Portion of Spain within Barclays Non-Core. Estimate as announced on 1 September 2014, subject to valuation upon completion of the sale | 2 Estimates based on current understanding of the BCBS 270 standards and the requirements contained in the European Commission delegated act |
23 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
CREDIT RATING
Credit ratings
24 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
CREDIT RATING
Barclays’ credit ratings remain strong and in line with peers’
As at 30 September 2014
Barclays PLC Barclays Bank PLC
Standard & Poor’s
Long Term A- (Negative) A (Negative)
Short Term X-0 X-0
Xxxxx-Xxxxx Credit Profile (SACP) n/a bbb+
Xxxxx’x
Long Term A3 (Negative) A2 (Negative)
Short Term P-2 P-1
Bank Financial Strength (BFS) n/a C- (Stable)
Fitch
Long Term A (Stable) A (Stable)
Short Term F1 F1
Viability Rating a a
DBRS
Long Term n/a AA low (Stable)
Short Term n/a R-1 middle (Stable)
Key Messages
Current ratings reflect Barclays’ “strong franchise”, “diverse revenue streams”, “good asset quality relative to peers”, “historically less volatile earnings than peers” and “sounds financial profile”
8 May strategy updated viewed as rating positive, albeit that execution risk balances long term benefits to ratings currently
Negative outlooks from S&P and Xxxxx’x reflect the expected removal of sovereign support notches for all UK banks. How many notches and over what period of time is currently unclear
On a standalone basis Barclays S&P (SACP) and Xxxxx’x (BFS) outlooks are stable
25 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
CREDIT RATING
Barclays manages and reserves for potential rating actions in the liquidity pool
Contractual credit rating downgrade exposure
(as at 31 December 2013)
Total cumulative cash outflow
(£bn) One-notch Two-notch
Securitisation derivatives 7 8
Contingent liabilities 6 6
Derivatives margining—1
Liquidity facilities 1 2
Total 14 17
Potential outflows related to a multiple-notch credit downgrade are included in the Liquidity Risk Appetite (LRA)
The table on the right hand side shows contractual collateral requirements and contingent obligations following potential future one and two notch long-term and associated short-term simultaneous downgrades across all credit rating agencies1
1 These numbers do not include the potential liquidity impact from loss of unsecured funding, such as from money market funds or loss of secured funding capacity |
26 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
CREDIT RATING
Summary
Business model
Capital
Leverage
Liquidity & funding
Regulation
Diversified international bank focused on delivering improved and more sustainable returns
Concentrating on our high growth opportunities where we have competitive advantage, eliminating marginal businesses and sharpening our focus on costs
Strengthened capital position with fully loaded CRD IV CET1 ratio of 10.2% as at 30 September 2014 with a plan to deliver a ratio of greater than 11% in 2016
Building on good track record in reducing RWAs as we run-down Barclays Non-Core and reinvest in Core businesses outside of the Investment Bank
Estimated BCBS leverage ratio of 3.5% as at 30 September 2014. Aim to deliver a ratio of greater than 4% in 2016 with flexibility to adapt to higher requirements in end-state if required
Planned reduction in leverage exposure by 2016 mainly through reduction in Barclays Non-Core and the Core Investment Bank
Diversified funding base, combining customer deposits and wholesale funding, in multiple currencies and different maturities
Robust liquidity position, well positioned to meet anticipated future regulatory requirements
Proactive and practical approach to managing regulatory changes
Established track record of adapting to regulatory change
27 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
APPENDIX -
STRATEGY
Appendix—Strategy
28 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
APPENDIX -STRATEGY
Repositioning and simplifying Barclays
Rightsizing and focusing the Investment Bank
Establishing a dedicated Non-Core unit and a new Personal & Corporate Banking business
Allocating capital to growth businesses Delivering a structurally lower cost base Generating higher and more sustainable returns
29 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
APPENDIX –STRATEGY
2016 Transform financial commitments
1 Capital CRD IV FL CET1 ratio >11.0%
Group 2 Leverage Leverage ratio >4.0%
3 Dividend Payout ratio 40-50%
4 Returns Adjusted XxX >12%
Barclays Core
Adjusted operating expenses
5 Cost <£14.5bn
Barclays Non-Core 6 Returns Drag on adjusted XxX <(3%)
30 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
APPENDIX -
STRATEGY
Reorganising to a simpler, focused and balanced structure
Barclays Group1
Personal & Corporate Banking
PBT £2,257m
RWAs £120.0bn
Barclaycard
PBT £1,126m
RWAs £38.6bn
Africa Banking
PBT £756m
RWAs £37.9bn
Investment Bank
PBT £1,342m
RWAs £127.9bn
Barclays Non-Core (BNC)
LBT £648m
RWAs £81.0bn
Adjusted results2
Income £18.7bn Risk weighted assets (RWA) £332bn
Impairment (£1.4bn) Average allocated equity £41bn
Operating expenses (£11.7bn) Return on average equity (XxX) 10.5% XxX drag (4.2%)
Profit before tax £5.6bn Return on tangible equity (RoTE) 12.8%
1 All figures for nine months ended September 2014 | 2 Includes Head Office as part of Core, representing £7.5bn RWAs and £106m profit before tax |
31 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
APPENDIX -
STRATEGY
Core Investment Bank:
Building on competitive advantages
Core Investment Bank
1 RWAs: c.£120bn
FY 2013 Leverage exposure: c.£490bn
Global Equities
• Cash Equities
• Equity Derivatives
Markets • Equity Prime
Global Credit
Credit Products
Securitised Products
Municipals
Right-sized Macro
Foreign Exchange
Rates
Fixed income secondary trading to be standard, cleared
and collateralised, short term and executed on the
electronic flow platform where relevant
ECM DCM
Banking Advisory Origination led
Build on leading positions in our home markets of the UK and the US, where we are already well positioned
Exit those products with low returns under new regulatory rules
Structurally lower the cost base through infrastructure efficiencies and refining the client proposition
Improve capital efficiency of Markets businesses
Non-core Investment Bank
RWAs: c.£90bn Leverage exposure: c.£340bn
Markets
Exit Quadrant Assets
Most physical commodities
Certain Emerging Markets products
Capital intensive Macro transactions
Principal Businesses
Investments
Credit
Banking
Front-to-back efficiency driven headcount reductions
1 CRD IV basis |
32 | Fixed Income Investor Presentation – Q3 2014 IMS
Preliminary numbers as presented at the Group Strategy Update on 8th
May
|
|
APPENDIX -STRATEGY
<15% and reallocating RWAs to drive growth and
returns
2013 pre-resegmentation (£bn) 2013 post-resegmentation estimate(£bn) 2016 guidance (£bn)
Leverage exposure £1.4tn £1.4tn c.£1.1tn1
RWAs £436bn £436bn c.£400bn
c.55%
BNC BNC
Retail and 26% c.115 c.50 <15%
Commercial +15%
214 49%
Core
Core (excl. IB) c.55%
46% (excl. IB) c.230
c.200
Investment Maintained
Bank 51%
222 Core IB Core IB
28% c.120 c.120 £30%
The Core Investment Bank will represent no more than 30% of the Group’s RWAs
1 2016 leverage exposure estimated on the basis of calculation methodology set out in BCBS Jan-14 proposals. All other regulatory metrics calculated on a CRD IV basis
33 | Fixed Income Investor Presentation – Q3 2014 IMS
Preliminary numbers as presented at the Group Strategy Update on 8th
May
|
|
APPENDIX -STRATEGY
Evolving balance of the Core business
Profit before tax of Core business: Q3 YTD 131
Profit before tax of Core business: Q3 YTD 141
Personal and Corporate Banking
Investment Bank
Non- Investment Bank 63%
Non- Investment Bank 76%
Personal and Corporate Banking
Investment Bank
Africa Banking
Africa Banking
Barclaycard
Barclaycard
1,342
2,156 1,907
2,257
756
927
846 1,126
1 Excluding Head Office |
34 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
APPENDIX -
STRATEGY
Core businesses expected to maintain average adjusted XxX >12% on a much higher equity base
%
Core >12
c.12
Non-Core
c.3 drag <3%
c.6 c.9-10
6.1
4.5 1.6 Group
>9%
3.5
1.0
0000 Xxxxxxxxx XxX Adjusting items 2013 Adjusted XxX CTA 2013 Adjusted XxX excl. CTA Group Non-core drag
Average allocated equity (£bn) 53
2013 Core XxX 2013-16 Capital accretion Proforma core XxX Income growth/ cost reduction 2016 Core adjusted XxX target
Core Core
c.36 48-50
Core businesses estimated to deliver adjusted XxX excluding CTA of >12% by 2016, achieved through:
Net Core cost savings of greater than £1.7bn
Growth in our retail and corporate franchises and selected IB businesses
Continuous optimisation of Core Investment Bank RWAs
Returns target takes into account increase in the total equity base to meet CET1 and leverage ratio targets These plans will reduce the XxX drag from Barclays Non-Core from c.6% to <3% in 2016, of which c.50bps is Europe retail
35 | Fixed Income Investor Presentation – Q3 2014 IMS
Preliminary numbers as presented at the Group Strategy Update on 8th
May
|
|
APPENDIX -STRATEGY
Operating expenses1 progress (£m)
(8%)
4,734
(14%)
4,500
4,282 4,223
4,130
4,042
3,879
Q1 13 Q2 13 Q3 13 Q4 13 Q1 14 Q2 14 Q3 14
Litigation & 48 77 39 277 65 146 98
Conduct Costs
Costs to Achieve 514 126 101 468 240 254 332
CTA outlook (£bn)
CTA YTD Expected CTA
1.3
0.7
0.8 0.2
FY 14 FY 15 FY 16
CTA spend to date Savings initiatives from CTA
Operating expenses significantly reduced
Personal and Corporate Banking
Barclaycard
Africa Banking
Investment Bank
Core2
Non-Core
589
117
54
542
1,326
709
2,600 FTE reduction from increased customers’ self-serve and assisted service
Increased digitalisation and automation, including New Client Service operations, and streamlining of wealth business
model
Savings from operational enhancements including restructuring and site consolidation, along with improved technical
capabilities through automation and digitisation
Savings from rationalisation of branch footprint and integrating technology across Africa
Front Office restructuring of c.800 FTE, plus additional infrastructure savings
Business exits, branch rationalisation in Europe and other efficiency savings
1 Excluding litigation and conduct costs, CTA, and UK Bank Levy | 2 Includes £24m of Head Office CTA spend to date |
36 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
APPENDIX -STRATEGY
Group Cost targets
Group cost guidance1 (£bn)
Original Group cost target and interim guidance Revised Group cost guidance
19 18.7 c.(9%) c.(13%)
18
c.17
17 c. 17
2013 2014 2015
Costs to achieve Transform (CTA)
£1.2bn c.£1.3b c.£0.7bn2
n
Core cost targets1 (£bn)
Core cost targets
c.(10%)
c.16.2
<14.5
2013 2016
1 Excludes provisions for PPI and IRHP redress, goodwill impairment and CTA | 2 £200m of CTA expected in 2016 across both Core and Non-Core |
37 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
APPENDIX-DATA
Appendix-Data
38 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
APPENDIX-DATA
Core customer assets and NIM growth driving NII
Core income
Nine months ended – September (£m) 2013 2014
Personal and Corporate Banking 6,557 6,597
Barclaycard 3,069 3,247
Africa Banking 3,059 2,701
Investment Bank 6,814 5,922
Total Core Income1 19,414 18,682
Net interest margin2,3 (bps)
416
410 410
400 403
Q3 13 Q4 13 Q1 14 Q2 14 Q3 14
Average customer assets and liabilities2 (£bn)
400 Customer assets Customer liabilities
273 328 273 328 275 325 278 327 281 335
Q3 13 Q4 13 Q1 14 Q2 14 Q3 14
Steady performance in PCB and Barclaycard income
PCB grew NII 6.6% driven by improved savings margins and mortgage income growth, partially offset by decline in fee income
Barclaycard grew NII 8.3% driven by volume growth
Africa Banking income was up 8% excluding currency impact, with NII up 10% on the same basis
NIM increased from 403 to 416bps QoQ, measured across PCB, Barclaycard and Africa Banking—YTD NIM of 409bps
NII for these businesses grew 5.8% to £2.9bn QoQ, reflecting modest growth in both NIM and customer assets
Average customer assets increased 1.3% to £281bn QoQ, with growth in PCB, Barclaycard and Africa Banking
Average customer assets for nine months ended September 2014 was £278bn
1 Includes Head Office income | 2 For Personal and Corporate Banking, Barclaycard and Africa Banking | 3 Using customer assets as the denominator |
39 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
APPENDIX-DATA
Capital resources1
(£m)
Shareholders’ equity (excluding non controlling interests) per the balance sheet
Less: other equity instruments (recognised as AT1 capital)
Adjustment to retained earnings for foreseeable dividends
Minority interests (amount allowed in consolidated CET1)
Additional value adjustments
Goodwill and intangible assets2
Deferred tax assets that rely on future profitability excluding temporary differences
Other regulatory adjustments and deductions
Fair value reserves related to gains or losses on cash flow hedges2
Negative amounts resulting from the calculation of expected loss amounts
Gains or losses on liabilities at fair value resulting from own credit2
Other regulatory adjustments
Direct and indirect holdings by an institution of own CET1 instruments
Fully loaded Common Equity Tier 1 capital
Regulatory adjustments relating to unrealised gains2
PRA Transitional Common Equity Tier 1 capital
CRD IV RWAs
Fully Loaded Common Equity Tier 1 ratio
PRA Transitional Common Equity Tier 1 ratio3
30 June 2014 30 September 2014
58,068 59,571
(4,326) (4,317)
(596) (787)
1,171 1,182
(2,492) (2,641)
(7,828) (7,953)
(1,062) (945)
(532) (617)
(2,036) (1,914)
612 581
(172) (88)
(25) (27)
40,782 42,045
(513) (604)
40,269 41,441
410,987 412,892
9.9% 10.2%
9.8% 10.0%
1 The Capital Requirements Regulation and Capital Requirements Directive implemented Basel 3 within the EU (collectively known as CRD IV) on 1 January 2014. The rules are supplemented by Regulatory Technical Standards and the PRA’s rulebook, including the implementation of transitional rules | 2 The capital impacts of these items are net of tax | 3 The CRD IV CET1 ratio (FSA October 2012 transitional statement) as applicable to Barclays’ Tier 2 Contingent Capital Notes was 12.1% based on £50bn of transitional CRD IV CET1 capital and £413bn RWAs |
40 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
APPENDIX—DATA
Estimated leverage exposure1
BCBS 270 Leverage exposure
(£bn)
Derivative financial instruments
Cash collateral
Reverse repurchase agreements
Loans and advances and other assets
Total IFRS assets
Derivatives netting
Adjustments to cash collateral
Net written credit protection
Potential Future Exposure on derivatives
Total derivatives adjustments
Securities financing transactions adjustments
Regulatory deductions and other adjustments
Weighted off balance sheet commitments
Total fully loaded leverage exposure
CRD IV Common Equity Tier 1 capital
CRD IV Additional Tier 1 capital
CRD IV Tier 1 capital
Fully loaded leverage ratio
30 June 2014 30 September 2014
333 383
60 60
172 158
750 765
1,315 1,366
(298) (345)
(31) (42)
29 28
195 195
(105) (164)
56 34
(18) (22)
105 110
1,353 1,324
40.8 42.0
4.6 4.6
45.4 46.6
3.4% 3.5%
1 Estimates based on current understanding of the BCBS 270 standards and the requirements contained in the European Commission delegated act |
41 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
APPENDIX—DATA
Wholesale funding composition as at H1 141
As at 30 June 2014 (£bn)
Deposits from banks
Certificates of deposit and commercial paper
Asset backed commercial paper
Senior unsecured MTNs
(public benchmark)
Senior unsecured MTNs
(private placement)
Covered bonds / ABS
Subordinated liabilities
Other2
Total
Of which secured
Of which unsecured
Total as at 31 December 2013
Of which secured
Of which unsecured
?1 month
10.0
2.4
2.8
1.5
1.3
-
-
3.5
21.5
5.0
16.5
20.3
4.6
15.7
>1 month but ?3 months
6.8
8.8
2.5
0.1
2.4
3.2
-
1.4
25.2
6.7
18.5
24.0
3.7
20.3
>3 months but ?6 months
>6 months but ?12 months
>9 months but ?12 months
Total ?1 year
>1 year but ?2 years
>2 years but ?5 years
>5 years
Total
1.0 4.6 0.1 22.5 0.3 0.2—23.0
6.4 3.7 3.0 24.3 0.5 1.1 0.4 26.3
0.1 — 5.4 ——5.4
0.1 2.0 0.6 4.3 2.6 7.6 6.2 20.7
2.5 4.1 3.1 13.4 7.8 15.5 11.9 48.6
0.2 4.0 1.7 9.1 3.8 4.1 7.3 24.3
- 0.1—0.1—2.8 15.6 18.5
0.7 0.5 0.3 6.4 2.2 1.4 2.1 12.1
11.0 19.0 8.8 85.5 17.2 32.7 43.5 178.9
0.9 4.5 1.9 19.0 4.2 4.4 7.4 35.0
10.1 14.5 6.9 66.5 13.0 28.3 36.1 143.9
15.5 15.9 6.3 82.0 27.1 33.8 42.6 185.5
1.4 3.5 0.7 13.9 7.3 6.5 7.2 34.9
14.1 12.4 5.6 68.1 19.8 27.3 35.4 150.6
1 The composition of wholesale funds comprises the balance sheet reported deposits from banks, financial liabilities at fair value, debt securities in issue and subordinated liabilities, excluding cash collateral and settlement balances. It does not include collateral swaps, including participation in the Bank of England’s Funding for Lending Scheme. Included within deposits from banks are £4bn of liabilities drawn in the European Central Bank’s 3 year LTRO. | 2 Primarily comprised of fair value deposits £4bn and secured financing of physical gold £5bn |
42 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
APPENDIX—DATA
Reduced exposure to the Eurozone
As at 30 June 2014 (£m) Spain Italy Portugal Ireland Total
Sovereign 134 1,898 165 30 2,227
Financial institutions 753 681 43 2,972 4,449
Corporate 2,736 1,377 653 1,394 6,160
Residential mortgages 11,710 14,284 3,187 92 29,273
Other retail lending 1,984 1,592 1,370 88 5,034
Total1 17,317 19,832 5,418 4,576 47,143
Total as at 31 December 2013 19,245 20,628 6,262 6,658 52,793
1 Total net on-balance sheet exposure as at 30 June 2014 for Cyprus and Greece was £223m (2013: £175m) and £74m respectively (2013: £82m)
43 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
APPENDIX—DATA
In line with the European Bank Recovery & Resolution Directive the UK Banking Act will include a statutory bail-in power
Overview
Statutory bail-in of debt is a key part of the regulatory response to the financial crisis aimed at avoiding the bail-out of failing financial institutions with tax payer funds
European Bank Recovery and Resolution Directive (“BRRD”): a European-wide framework for the recovery and resolution of credit institutions and investment firms:
statutory “bail-in” power in respect of eligible liabilities, to be implemented in home state legislation by no later than 1 January 2016 (Article 130)
requirement for eligible liabilities governed by non-EEA laws to include a contractual recognition by creditors that they are bound by any exercise of the statutory bail-in power (Article 55).
UK Banking Act: in anticipation of the BRRD, the UK Banking Act was amended in 2013 to introduce a “bail-in option” available to the UK resolution authority, enabling it recapitalise a failed institution by allocating losses to its shareholders and unsecured creditors by writing down and/or converting their claims to equity:
certain liabilities excluded from scope, such as insured deposits, secured liabilities (Section 48B(8))
powers to be exercised broadly in a manner that respects the hierarchy of claims in liquidation
principle that at least senior creditors should receive no less favourable treatment than they would have received in an insolvency.
UK bail-in powers are currently the subject of consultation, however they are expected to be implemented at least by 1 Jan 2015, ahead of BRRD timeline.
Considerations for Bondholders
The BRRD introduces seniority of deposits from natural persons and SMEs over wholesale liabilities
The scope of the UK bail-in power extends to include all outstanding unsecured wholesale liabilities of original tenor greater than 7 days
Liabilities issued prior to the introduction of the statutory bail-in power, including those issued under non-EEA governing laws, are not ‘excluded liabilities’ (i.e. all outstanding instruments with an original tenor greater than 7 days may be subject to bail-in upon its introduction irrespective of issuance date)
Guiding principle is that the ordinary creditor hierarchy should be respected and that creditors holding eligible liabilities of equal rank should be treated equally
In light of Article 55 of the BRRD, and as requested by the PRA, Barclays has begun the process of including in the terms of its wholesale term debt securities, governed by non-EEA laws, a provision acknowledging the scope of the UK bail-in power
Note, the inclusion of such an acknowledgement is not intended to change the ranking or treatment of such non-EEA law governed instruments relative to EEA law governed instruments in respect of a UK bail-in, rather it clarifies that all such instruments should be treated equally in the event of a UK bail-in.
44 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
APPENDIX—DATA
CRD IV—Regulatory timeline
Timeframe based on Capital Requirements Regulation (CRR) and Capital Requirements Directive (CRD) published in June
H1 2010 1 Jan 2011 1 Jan 2012 1 Jan 2013 1 Jan 2014 1 Jan 2015 1 Jan 2016 1 Jan 2017 1 Jan 2018 1 Jan 2019
Capital requirements Phased-in capital requirements
CRD IV leverage ratio1 Supervisory monitoring Parallel run (Jan 2014 – Jan 2017) Public disclosures starts in Jan 2015 Binding requirement
Net Stable Funding Ratio (NSFR) Observation period Introduction of minimum requirement
Liquidity Coverage Ratio (LCR)2 60% compliance required Phase in to full compliance Full compliance required
Intraday liquidity monitoring tools3 Introduction of monthly reporting
FSA/PRA’s Individual Liquidity Guidance (ILG)4 Introduction of ILG
[Graphic Appears Here]
Fully phased-in main requirements
Capital: minimum of 4.5% CET1 + 1.5% AT1 + 2% T2 (Art. 92 of CRR). Banks are also subject to capital buffers, including a capital conservation buffer of 2.5%, a countercyclical buffer of 0-2.5% (outside periods of stress) and a G-SII buffer of up to 2.5% (2% for Barclays) to be satisfied with CET1
CRD IV Leverage: minimum requirement still to be determined, but currently expected to be at 3%
NSFR: available amount of stable funding to exceed required amount of stable funding, over a stress 1-year period (NSFR > 100%)
1 Basel • LCR: Committee stock is currently of unencumbered consulting on revisions to high the leverage quality ratio framework liquid assets including disclosure; to exceed please not net that stressed large UK banks cash have outflow been requested over to publicly 30 days disclose (LCR the ratio > since 100%) Jan 2013 . | 2 Estimated LCR on a CRDIV basis as implemented by the EBA. Note that CRDIV requires full compliance by 1 Jan 2018 with a phased implementation in the preceding years. LCR compliance of 60% in 2015 increases by 10% in 2016 & 2017 with a further 20% increase in 2018 | 3 As per “Monitoring tools for intraday liquidity management”, April 2013 | 4 Short-term liquidity stress test, broadly comparable to the LCR under Basel 3; as per its August 2013 announcement, the PRA has relaxed the ILG requirements for major UK banks to approximate 80% LCR |
45 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
Contact—Debt Investor Relations Team
Xxxxxxx Xxxxx
Xxxxx Xxxxxxxxx
x00 (0)00 0000 0000
x00 (0)00 0000 0000
xxxxxxx.xxxxx@xxxxxxxx.xxx
xxxxx.xxxxxxxxx@xxxxxxxx.xxx
Website: xxxxxxxx.xxx/xxxxxxxx-xxxxxxxx-xxxxxxxxx.xxxx
46 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
Disclaimer
Important Notice
The information, statements and opinions contained in this document do not constitute a public offer under any applicable legislation or an offer to sell or solicitation of any offer to buy any securities or financial instruments or any advice or recommendation with respect to such securities or other financial instruments.
Forward-looking Statements
This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to certain of the Group’s plans and its current goals and expectations relating to its future financial condition and performance. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking statements. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’, ‘target’, ‘projected’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar meaning. Examples of forward-looking statements include, among others, statements regarding the Group’s future financial position, income growth, assets, impairment charges and provisions, business strategy, capital, leverage and other regulatory ratios, payment of dividends (including dividend pay-out ratios), projected levels of growth in the banking and financial markets, projected costs or savings, original and revised commitments and targets in connection with the Transform Programme and Group Strategy Update, run-down of assets and businesses within Barclays Non-Core, estimates of capital expenditures and plans and objectives for future operations, projected employee numbers and other statements that are not historical fact. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. These may be affected by changes in legislation, the development of standards and interpretations under International Financial Reporting Standards (IFRS), evolving practices with regard to the interpretation and application of accounting and regulatory standards, the outcome of current and future legal proceedings and regulatory investigations, future levels of conduct provisions, the policies and actions of governmental and regulatory authorities, geopolitical risks and the impact of competition. In addition, factors including (but not limited to) the following may have an effect: capital, leverage and other regulatory rules (including with regard to the future structure of the Group) applicable to past, current and future periods; UK, US, Africa, Eurozone and global macroeconomic and business conditions; the effects of continued volatility in credit markets; market related risks such as changes in interest rates and foreign exchange rates; effects of changes in valuation of credit market exposures; changes in valuation of issued securities; volatility in capital markets; changes in credit ratings of the Group; the potential for one or more countries exiting the Eurozone; the impact of EU and US sanctions on Russia; the implementation of the Transform Programme; and the success of future acquisitions, disposals and other strategic transactions. A number of these influences and factors are beyond the Group’s control. As a result, the Group’s actual future results, dividend payments, and capital and leverage ratios may differ materially from the plans, goals, and expectations set forth in the Group’s forward-looking statements. Additional risks and factors are identified in our filings with the SEC including our Annual Report on Form 20-F for the fiscal year ended 31 December 2013, which are available on the SEC’s website at xxxx://xxx.xxx.xxx.
Any forward-looking statements made herein speak only as of the date they are made and it should not be assumed that they have been revised or updated in the light of new information or future events. Except as required by the Prudential Regulation Authority, the Financial Conduct Authority, the London Stock Exchange plc (the LSE) or applicable law, Barclays expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Barclays’ expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. The reader should, however, consult any additional disclosures that Barclays has made or may make in documents it has published or may publish via the Regulatory News Service of the LSE and/or has filed or may file with the SEC.
47 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
Disclaimer (continued)
Barclays has filed a registration statement (including a prospectus) and has filed, or will file, a prospectus supplement with the U.S. Securities and Exchange Commission (“SEC”) for the offering of securities to which this document relates. Before you invest, you should read the prospectus in that registration statement, the prospectus supplement relating to the offering of the Securities (when filed) and other documents that Barclays will file with the SEC. You may get these documents for free by searching the SEC online database (XXXXX®) at xxx.xxx.xxx. Alternatively, you may obtain a copy of the prospectus from Barclays Capital Inc. by calling 0-000-000-0000.
Certain non-IFRS Measures
Barclays management believes that the non-International Financial Reporting Standards (non-IFRS) measures included in this document provide valuable information to readers of its financial statements because they enable the reader to identify a more consistent basis for comparing the business’ performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays management. However, any non-IFRS measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. As management reviews the adjusting items described below at a Group level, segmental results are presented excluding these items in accordance with IFRS 8; “Operating Segments”. Statutory and adjusted performance is reconciled at a Group level only. Key non-IFRS measures included in this document and the most directly comparable IFRS measures are described below. Quantitative reconciliations of these measures to the relevant IFRS measures are included in Exhibit 99.1 of the Barclays Form 6-K filed with the SEC on October 30, 2014 (Film No. 141182511) (the “October 30 Form 6-K”) (xxxx://xxx.xxx.xxx/Xxxxxxxx/xxxxx/xxxx/000000/000000000000000000/x000000xxx000.xxx), and such quantitative reconciliations are incorporated by reference into this document.
Adjusted profit before tax is the non-IFRS equivalent of profit before tax as it excludes the impact of own credit; provisions for Payment Protection Insurance and claims management costs (PPI) and interest rate hedging redress; gain on US Xxxxxx acquisition assets; provision for ongoing regulatory investigations into Foreign Exchange; loss on announced sale of the Spanish business; and goodwill impairment. A reconciliation to IFRS is presented on page 4 of the October 30 Form 6-K;
Adjusted profit after tax represents profit after tax excluding the post-tax impact of own credit; provisions for PPI and interest rate hedging redress; the gain on US Xxxxxx acquisition assets; provision for ongoing regulatory investigations into Foreign Exchange; loss on announced sale of the Spanish business; and goodwill impairment. A reconciliation to IFRS is presented on page 4 of the October 30 Form 6-K;
Adjusted attributable profit represents adjusted profit after tax less profit attributable to non-controlling interests. The comparable IFRS measure is attributable profit;
48 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
Disclaimer (continued)
Adjusted income and adjusted total income net of insurance claims represents total income net of insurance claims excluding the impact of own credit; and the gain on US Xxxxxx acquisition assets. A reconciliation to IFRS is presented on page 17 of the October 30 Form 6-K;
Adjusted net operating income represents net operating income excluding the impact of own credit; and gain on US Xxxxxx acquisition assets. A reconciliation to IFRS is presented on page 17 of the October 30 Form 6-K;
Adjusted total operating expenses represents operating expenses excluding the provisions for PPI and interest rate hedging redress; provision for ongoing regulatory investigations into Foreign Exchange; and goodwill impairment. A reconciliation to IFRS is presented on page 17 of the October 30 Form 6-K;
Adjusted litigation and conduct represents litigation and conduct excluding the provisions for PPI and interest rate hedging redress; and the provision for ongoing regulatory investigations into Foreign Exchange. A reconciliation to IFRS is presented on page 17 of the October 30 Form 6-K;
Adjusted cost: income ratio represents cost: income ratio excluding the impact of own credit; the provisions for PPI and interest rate hedging redress; gain on US Xxxxxx acquisition assets; and provision for ongoing regulatory investigations into Foreign Exchange. The comparable IFRS measure is cost: income ratio, which represents operating expenses to income net of insurance claims. A reconciliation to IFRS is presented on page 17 of the October 30 Form 6-K;
Adjusted basic earnings per share represents adjusted attributable profit (see page 21 of the October 30 Form 6-K) divided by the basic weighted average number of shares in issue. The comparable IFRS measure is basic earnings per share, which represents profit after tax and non-controlling interests, divided by the basic weighted average number of shares in issue;
Adjusted return on average shareholders’ equity represents adjusted attributable profit (see page 21 of the October 30 Form 6-K) divided by adjusted average equity, excluding non-controlling interests. The comparable IFRS measure is return on average shareholder’s equity, which represents profit attributable to equity holders of the parent divided by average equity, excluding non-controlling interests;
Adjusted return on average tangible shareholders’ equity represents adjusted attributable profit (see page 21 of the October 30 Form 6-K) divided by average adjusted tangible equity, excluding non-controlling interests. The comparable IFRS measure is return on average tangible shareholders’ equity, which represents profit after tax and non-controlling interests, divided by average tangible equity (see page 21 of the October 30 Form 6-K);
Barclays Core results are non-IFRS measures because they represent the sum of five Operating Segments, each of which is prepared in accordance with IFRS 8; “Operating Segments”: Personal and Corporate Banking, Barclaycard, Africa Banking, Investment Bank and Head Office. A reconciliation to is provided on pages 18 and 19 of the October 30 Form 6-K;
49 | Fixed Income Investor Presentation – Q3 2014 IMS
|
|
Disclaimer (continued)
‘Constant Currency Basis’ excludes the impact of foreign currency conversion to GBP when comparing financial results in two different financial periods. ZAR has been translated into GBP at prior-year average exchange rates to eliminate the impact of movement in exchange rates between the comparable periods;
Liquidity Coverage Ratio (LCR) is calculated according to the Commission Delegated Regulation of October 2014 that supplements Regulation (EU) 575/2013 (CRDIV) published by the European Commission in June 2013. The metric is a ratio that is not yet fully implemented in local regulations and, as such, represents a non-IFRS measure
Estimated Net Stable Funding Ratio (NSFR) is calculated according to the definition and methodology detailed in the standard provided by the Basel Committee on Banking Supervision. The original guidelines released in December 2010 (‘Basel III: International Framework for Liquidity Risk Measurement, Standards and Monitoring’, December 2010) were revised in January 2014 (‘Basel III: The Net Stable Funding Ratio’, January 2014).
The metric is a regulatory ratio that is not yet finalised in local regulations and, as such, represents a non-IFRS measure. This definition and the methodology used to calculate this metric is subject to further revisions ahead of the implementation date and Barclays’ interpretation of this calculation may not be consistent with that of other financial institutions;
Transitional CET1 ratio according to FSA October 2012. This measure is calculated by taking into account the statement of the Financial Services Authority, the predecessor of the Prudential Regulation Authority, on CRD IV transitional provisions in October 2012, assuming such provisions were applied as at 1 January 2014. This ratio is used as the relevant measure starting 1 January 2014 for purposes of determining whether the automatic write-down trigger (specified as a Transitional CET1 ratio according to FSA October 2012 of less than 7.00%) has occurred under the terms of the Contingent Capital Notes issued by Barclays Bank PLC on November 21, 2012 (CUSIP: 00000X0X0) and April 10, 2013 (CUSIP: 00000XXX0). Please refer to page 26 of the October 30 6-K for a reconciliation of this measure to CRD IV CET1 ratio;
Estimated BCBS 270 leverage exposure makes certain adjustments to Total assets under IFRS in accordance with Barclays’ understanding of the latest requirements that are expected to be included in the revised CRD IV text and guidance from regulators. The “Estimated Leverage” table on page 28 of the October 30 6-K shows a reconciliation of BCBS 270 leverage exposure to total assets under IFRS;
Estimated BCBS 270 leverage ratio represents CRD IV Tier 1 capital divided by BCBS 270 leverage exposure. See the “Estimated Leverage” table on page 28 of the October 30 6-K for a reconciliation of BCBS 270 leverage exposure to Total assets under IFRS;
The CRD IV fully loaded CET1 and estimated BCBS 270 leverage ratios excluding the impact of the announced sale of the Spanish business are non- IFRS measures as these metrics exclude the impact of the risk weighted assets associated with the Spanish business.
50 | Fixed Income Investor Presentation – Q3 2014 IMS
